Chargement en cours...
Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases
To enable the establishment of a drug discovery operation for neglected diseases, out of 2.3 million commercially available compounds 222 552 compounds were selected for an in silico library, 57 438 for a diverse general screening library, and 1 697 compounds for a focused kinase set. Compiling thes...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
WILEY-VCH Verlag
2008
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2628535/ https://ncbi.nlm.nih.gov/pubmed/18064617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cmdc.200700139 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|